These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8393158)

  • 1. p53 mutants with changes in conserved region II: three classes with differing antibody reactivity, SV40 T antigen binding and ability to inhibit transformation of rat cells.
    Schmieg FI; Simmons DT
    Oncogene; 1993 Aug; 8(8):2043-50. PubMed ID: 8393158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p53 tumor suppressor gene and gene product.
    Levine AJ
    Princess Takamatsu Symp; 1989; 20():221-30. PubMed ID: 2488233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The three transforming regions of SV40 T antigen are required for immortalization of primary mouse embryo fibroblasts.
    Conzen SD; Cole CN
    Oncogene; 1995 Dec; 11(11):2295-302. PubMed ID: 8570180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The properties of p53 proteins selected for the loss of suppression of transformation.
    Olson DC; Levine AJ
    Cell Growth Differ; 1994 Jan; 5(1):61-71. PubMed ID: 8123594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The growth-inhibitory function of p53 is separable from transactivation, apoptosis and suppression of transformation by E1a and Ras.
    Hansen RS; Braithwaite AW
    Oncogene; 1996 Sep; 13(5):995-1007. PubMed ID: 8806689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immortalization of BALB/c mouse embryo fibroblasts alters SV40 large T-antigen interactions with the tumor suppressor p53 and results in a reduced SV40 transformation-efficiency.
    Tiemann F; Deppert W
    Oncogene; 1994 Jul; 9(7):1907-15. PubMed ID: 8208537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transforming oncoproteins determine the mechanism by which p53 suppresses cell transformation: pRb-mediated growth arrest or apoptosis.
    Hansen R; Reddel R; Braithwaite A
    Oncogene; 1995 Dec; 11(12):2535-45. PubMed ID: 8545110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
    Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A
    Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of SV40 large T antigen induced apoptosis by small T antigen.
    Kolzau T; Hansen RS; Zahra D; Reddel RR; Braithwaite AW
    Oncogene; 1999 Sep; 18(40):5598-603. PubMed ID: 10523837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear localization is essential for the activity of p53 protein.
    Shaulsky G; Goldfinger N; Tosky MS; Levine AJ; Rotter V
    Oncogene; 1991 Nov; 6(11):2055-65. PubMed ID: 1719467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells.
    Müller E; Boldyreff B; Scheidtmann KH
    Oncogene; 1993 Aug; 8(8):2193-205. PubMed ID: 8393163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
    DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC
    Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperation of SV40 large T antigen and the cellular protein p53 in maintenance of cell transformation.
    Deppert W; Steinmayer T; Richter W
    Oncogene; 1989 Sep; 4(9):1103-10. PubMed ID: 2674854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the level of the oncoprotein p53 in non-transformed and transformed cells.
    Reihsaus E; Kohler M; Kraiss S; Oren M; Montenarh M
    Oncogene; 1990 Jan; 5(1):137-45. PubMed ID: 2157179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth stimulation of murine fibroblasts by TGF-beta1 depends on the expression of a functional p53 protein.
    Dkhissi F; Raynal S; Jullien P; Lawrence DA
    Oncogene; 1999 Jan; 18(3):703-11. PubMed ID: 9989820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limits of transforming competence of SV40 nuclear and cytoplasmic large T mutants with altered Rb binding sequences.
    Tedesco D; Fischer-Fantuzzi L; Vesco C
    Oncogene; 1993 Mar; 8(3):549-57. PubMed ID: 8382355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation.
    Woo RA; Poon RY
    Genes Dev; 2004 Jun; 18(11):1317-30. PubMed ID: 15175263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The induction of apoptosis by SV40 T antigen correlates with c-jun overexpression.
    Chen SL; Tsao YP; Chen YL; Huang SJ; Chang JL; Wu SF
    Virology; 1998 May; 244(2):521-9. PubMed ID: 9601520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of rare p53 mutants from carcinogen-treated albumin-simian virus 40 T-antigen transgenic rats.
    Haas MJ; Pitot HC
    Mol Carcinog; 1998 Feb; 21(2):128-34. PubMed ID: 9496913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D; Chilton-MacNeill S; Meister LA; Sexsmith E; Diller L; Garcea RL
    Oncogene; 2001 Jul; 20(33):4441-9. PubMed ID: 11494139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.